Blueshift Asset Management’s Core Laboratories CLB Stock Holding History

Blueshift Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,925	Closed	-$216K	–	624
2022 Q2	$216K	Buy	10,925 +2,533	+30%	+$67.3K	0.04%	553
2022 Q1	$265K	Buy	+8,392	New	+$235K	0.02%	654
2021 Q4	–	Sell	-12,462	Closed	-$346K	–	898
2021 Q3	$346K	Buy	12,462 +4,297	+53%	+$131K	0.02%	762
2021 Q2	$318K	Sell	8,165 -2,786	-25%	-$99.9K	0.02%	707
2021 Q1	$315K	Sell	10,951 -1,624	-13%	-$55.5K	0.03%	617
2020 Q4	$333K	Buy	+12,575	New	+$257K	0.04%	510

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Blueshift Asset Management's CLB Position: Q3 2022 in Review

Blueshift Asset Management sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 10,925 shares — an estimated $216K sold.

Blueshift Asset Management first reported a position in CLB in Q4 2020 and held it in 6 quarters. The position peaked at $346K in Q3 2021. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

Blueshift Asset Management reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
Blueshift Asset Management sold 10,925 Core Laboratories shares in Q3 2022, an estimated $216K.
Blueshift Asset Management first reported a position in Core Laboratories in Q4 2020 and held it in 6 quarters.
Blueshift Asset Management's Core Laboratories position peaked at $346K in Q3 2021.
162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Blueshift Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.